Israël - Hebreeuws - Ministry of Health

astrazeneca (israel) ltd - durvalumab - תמיסה לאינפוזיה - durvalumab 50 mg/ml - durvalumab

Israël - Hebreeuws - Ministry of Health

astrazeneca (israel) ltd - durvalumab - תמיסה לאינפוזיה - durvalumab 50 mg/ml - durvalumab

Israël - Hebreeuws - Ministry of Health

astrazeneca (israel) ltd - aclidinium bromide - אבקה לשאיפה - aclidinium bromide 0.4 mg - aclidinium bromide

Israël - Hebreeuws - Ministry of Health

astrazeneca (israel) ltd - aclidinium as bromide; formoterol fumarate dihydrate - אבקה לשאיפה - formoterol fumarate dihydrate 11.8 mcg; aclidinium as bromide 340 mcg - aclidinium bromide

Israël - Hebreeuws - Ministry of Health

astrazeneca (israel) ltd - benralizumab - תמיסה להזרקה - benralizumab 30 mg / 1 ml - benralizumab

Israël - Hebreeuws - Ministry of Health

astrazeneca (israel) ltd - trastuzumab deruxtecan - אבקה להכנת תמיסה מרוכזת לעירוי - trastuzumab deruxtecan 100 mg - trastuzumab

Israël - Hebreeuws - Ministry of Health

astrazeneca (israel) ltd - tremelimumab - תרכיז להכנת תמיסה לאינפוזיה - tremelimumab 20 mg / 1 ml - tremelimumab

Israël - Hebreeuws - Ministry of Health

taro international ltd, israel - esomeprazole - טבליה - esomeprazole 20 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

Israël - Hebreeuws - Ministry of Health

taro international ltd, israel - esomeprazole - טבליה - esomeprazole 40 mg - esomeprazole - esomeprazole - nexium tablets are indicated for: gastroesophageal reflux disease (gerd): - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastroesophageal reflux disease (gerd). in combination with an appropriate antibacterial therapeutic regimen for the eradication of helicobacter pylori and: - healing of helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with helicobacter pylory associated ulcers. - healing of gastric ulcers associated with nsaid therapy. - prevention of gastric and duodenal ulcers associated with nsaid therapy in patients at risk.prolonged treatment after i.v induced prevention of rebleeding of peptic ulcers.

Israël - Hebreeuws - Ministry of Health

taro international ltd, israel - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/dose - esomeprazole - esomeprazole - nexium iv is indicated for gastroesophageal reflux disease in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate.prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers.